Work That Holds Up Under Peer Review

Our studies contribute to peer-reviewed publications, industry presentations, and regulatory data packages. When our clients publish, we often publish with them.

October 30, 2018
Human-Derived Antibody against S. aureus α-Hemolysin
Mechanism of Action and In Vivo Efficacy of a Human-Derived Antibody against Staphylococcus aureus α-Hemolysin Pfizer
Read more
October 29, 2018
AZD9773 Anti-TNF-α Immune Fab in Murine CLP Sepsis
Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-a (TNF-a) using AZD9773, an anti-TNF-a immune Fab, in…
Read more
May 4, 2018
Zolav®: A New Antibiotic for the Treatment of Acne
Zolav®: A New Antibiotic for the Treatment of Acne Boulos and Cooper Pharmaceuticals
Read more
April 5, 2017
PaSASPject Efficacy against P. aeruginosa in a Mouse Lung Model
SASP: Efficacy of Pa SASPject against Pseudomonas aeruginosa ATCC 27853 in a Mouse Lung Model Phico Therapeutics
Read more
April 5, 2017
Targeted Antimicrobial Peptides against C. difficile Infection
Efficacy and Impact to the Microbiome of Novel Specifically-Targeted Antimicrobial Peptides against C. difficile Infection C3J Therapeutics
Read more
April 5, 2017
Diversity-Oriented Synthesis Inhibitors of C. difficile
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile Broad Institute of MIT and Harvard
Read more
April 5, 2017
CD101: Subcutaneous Echinocandin with Sustained Drug Exposure
Subcutaneous (SC) Injection of CD101, a Novel Echinocandin: Efficacious, Well-Tolerated, and Sustained Drug Exposures Cidara Therapeutics
Read more
October 10, 2010
Human Monoclonal Antibodies Neutralize Staphylococcal Enterotoxin B
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B Morphotek, Inc.
Read more

Ready to discuss your program?
Let's start a conversation.

Request a Quote